Home » Psychology news » Antidepressant with novel action appears safe and effective in phase 1b clinical trial
Antidepressant with novel action appears safe and effective in phase 1b clinical trial
December 8, 2015 by NewsBot
A small clinical trial of a novel antidepressant that stimulates neurogenesis - the production of new brain cells - shows that the compound appears to be safe and may be effective against depression.